COVID-19 Impact on Healthcare and Supportive Services for People Who Use Drugs (PWUDs) in Malaysia

por Vicknasingam, Balasingam, Mohd Salleh, Nur Afiqah, Chooi, Weng-Tink, Singh, Darshan, Mohd Zaharim, Norzarina, Kamarulzaman, Adeeba, Chawarski, Marek C.
Publicado 2021

Primary Care Office-based Buprenorphine Treatment: Comparison of Heroin and Prescription Opioid Dependent Patients

por Moore, Brent A., Fiellin, David A., Barry, Declan T., Sullivan, Lynn E., Chawarski, Marek C., O’Connor, Patrick G., Schottenfeld, Richard S.
Publicado 2007

Patient Satisfaction with Primary Care Office-Based Buprenorphine/Naloxone Treatment

por Barry, Declan T., Moore, Brent A., Pantalon, Michael V., Chawarski, Marek C., Sullivan, Lynn E., O’Connor, Patrick G., Schottenfeld, Richard S., Fiellin, David A.
Publicado 2007

Kratom and Pain Tolerance: A Randomized, Placebo-Controlled, Double-Blind Study

por Vicknasingam, Balasingam, Chooi, Weng Tink, Rahim, Azlan Abdul, Ramachandram, Dinesh, Singh, Darshan, Ramanathan, Surash, Yusof, Nur Sabrina Mohd, Zainal, Hadzliana, Murugaiyah, Vikneswaran, Gueorguieva, Ralitza, Mansor, Sharif Mahsufi, Chawarski, Marek C.
Publicado 2020

Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Proj...

por D’Onofrio, Gail, Edelman, E. Jennifer, Hawk, Kathryn F., Pantalon, Michael V., Chawarski, Marek C., Owens, Patricia H., Martel, Shara H., VanVeldhuisen, Paul, Oden, Neal, Murphy, Sean M., Huntley, Kristen, O’Connor, Patrick G., Fiellin, David A.
Publicado 2019

Barriers and Facilitators to Clinician Readiness to Provide Emergency Department–Initiated Buprenorphine

por Hawk, Kathryn F., D’Onofrio, Gail, Chawarski, Marek C., O’Connor, Patrick G., Cowan, Ethan, Lyons, Michael S., Richardson, Lynne, Rothman, Richard E., Whiteside, Lauren K., Owens, Patricia H., Martel, Shara H., Coupet, Edouard, Pantalon, Michael, Curry, Leslie, Fiellin, David A., Edelman, E. Jennifer
Publicado 2020

Kratom withdrawal: Discussions and conclusions of a scientific expert forum()

por Henningfield, Jack E., Chawarski, Marek C., Garcia-Romeu, Albert, Grundmann, Oliver, Harun, Norsyifa, Hassan, Zurina, McCurdy, Christopher R., McMahon, Lance R., Sharma, Abhisheak, Shoaib, Mohammed, Singh, Darshan, Smith, Kirsten E., Swogger, Marc T., Vicknasingam, Balasingam, Walsh, Zachary, Wang, Daniel W., Huestis, Marilyn A.
Publicado 2023

Implementation Facilitation to Promote Emergency Department–Initiated Buprenorphine for Opioid Use Disorder

por D’Onofrio, Gail, Edelman, E. Jennifer, Hawk, Kathryn F., Chawarski, Marek C., Pantalon, Michael V., Owens, Patricia H., Martel, Shara H., Rothman, Richard, Saheed, Mustapha, Schwartz, Robert P., Cowan, Ethan, Richardson, Lynne, Salsitz, Edwin, Lyons, Michael S., Freiermuth, Caroline, Wilder, Christine, Whiteside, Lauren, Tsui, Judith I., Klein, Jared W., Coupet, Edouard, O’Connor, Patrick G., Matthews, Abigail G., Murphy, Sean M., Huntley, Kristen, Fiellin, David A.
Publicado 2023